Home RxNorm 1373501 ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1373501
RxNorm name ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet
Display name Ethinyl estradiol/Levonorgestrel (Oral Pill)
Full name ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet
Term type SCD
Status Active
Strength 0.02-0.15 mg
Dose form Tab
Route Oral Pill
Updated 2026-11-16 14:56:56 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 052013
Active start 052013
Multiple ingredient YES
Branded NO
Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength ethinyl estradiol 0.02 MG / 1 EACH ethinyl estradiol ethinyl estradiol levonorgestrel 0.15 MG / 1 EACH levonorgestrel levonorgestrel
Derived Ingredient Concepts# RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Rosyrah LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL Xiromed, LLC d2f0af55-205f-df9c-c572-1f7b14976655 2025-11-10 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 1373501 Rivelsa LEVONORGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL Teva Pharmaceuticals USA, Inc. 822e56c6-562f-4299-bf4f-eaee0c0f2b7a 2024-10-31 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 1373501 LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL Mylan Pharmaceuticals Inc. 5c1d0a3a-1b24-44a0-9c53-224365b65945 2023-05-31 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 1373501
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 822e56c6-562f-4299-bf4f-eaee0c0f2b7a ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet [PSN] · ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet [SCD] 2 13 These highlights do not include all the information needed to use RIVELSA safely and effectively. See full prescribing information for RIVELSA. RIVELSA ® (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1982 20241022 5c1d0a3a-1b24-44a0-9c53-224365b65945 ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet [PSN] · ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet [SCD] 2 7 These highlights do not include all the information needed to use LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS, AND ETHINYL ESTRADIOL TABLETS, safely and effectively. See full prescribing information for LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS, AND ETHINYL ESTRADIOL TABLETS. LEVONORGESTREL and ETHINYL ESTRADIOL tablets, and ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 1982 20230531 d2f0af55-205f-df9c-c572-1f7b14976655 ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet [PSN] · ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet [SCD] 2 2 These highlights do not include all the information needed to use ROSYRAH, safely and effectively. See full prescribing information for ROSYRAH. ROSYRAH, for oral use Initial U.S. Approval: 1982 20251110
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC G03AD Emergency contraceptives ATC1-4 levonorgestrel ATC L02AA Estrogens ATC1-4 ethinyl estradiol ATC G03CA Natural and semisynthetic estrogens, plain ATC1-4 ethinyl estradiol ATC G03AC Progestogens ATC1-4 levonorgestrel ATC G03AA Progestogens and estrogens, fixed combinations ATC1-4 ethinyl estradiol / levonorgestrel ATC G03AB Progestogens and estrogens, sequential preparations ATC1-4 ethinyl estradiol / levonorgestrel FDASPL D045167 Progesterone Congeners CHEM has_chemical_structure levonorgestrel FDASPL N0000175825 Estrogen EPC has_epc ethinyl estradiol FDASPL N0000175602 Progestin EPC has_epc levonorgestrel FDASPL N0000175832 Progestin-containing Intrauterine System EPC has_epc levonorgestrel FDASPL N0000000100 Estrogen Receptor Agonists MOA has_moa ethinyl estradiol FDASPL N0000175830 Inhibit Ovum Fertilization PE has_pe levonorgestrel MEDRT D004997 Ethinyl Estradiol CHEM has_ingredient ethinyl estradiol MEDRT D016912 Levonorgestrel CHEM has_ingredient levonorgestrel MEDRT D000022 Abortion, Spontaneous DISEASE induces levonorgestrel MEDRT D018248 Adenoma, Liver Cell DISEASE ci_with levonorgestrel MEDRT D001943 Breast Neoplasms DISEASE ci_with ethinyl estradiol MEDRT D001943 Breast Neoplasms DISEASE may_treat ethinyl estradiol MEDRT D001943 Breast Neoplasms DISEASE ci_with levonorgestrel MEDRT D002539 Cerebral Arterial Diseases DISEASE ci_with ethinyl estradiol MEDRT D002561 Cerebrovascular Disorders DISEASE ci_with levonorgestrel MEDRT D003324 Coronary Artery Disease DISEASE ci_with ethinyl estradiol MEDRT D003327 Coronary Disease DISEASE ci_with levonorgestrel MEDRT D003920 Diabetes Mellitus DISEASE ci_with levonorgestrel MEDRT D004342 Drug Hypersensitivity DISEASE ci_with ethinyl estradiol MEDRT D004342 Drug Hypersensitivity DISEASE ci_with levonorgestrel MEDRT D016889 Endometrial Neoplasms DISEASE ci_with ethinyl estradiol MEDRT D016889 Endometrial Neoplasms DISEASE ci_with levonorgestrel MEDRT D020773 Headache Disorders DISEASE ci_with levonorgestrel MEDRT D006349 Heart Valve Diseases DISEASE ci_with levonorgestrel MEDRT D019584 Hot Flashes DISEASE may_treat ethinyl estradiol MEDRT D006973 Hypertension DISEASE ci_with levonorgestrel MEDRT D006973 Hypertension DISEASE ci_with ethinyl estradiol MEDRT D007006 Hypogonadism DISEASE may_treat ethinyl estradiol MEDRT D007565 Jaundice DISEASE ci_with levonorgestrel MEDRT D007674 Kidney Diseases DISEASE ci_with levonorgestrel MEDRT D008107 Liver Diseases DISEASE ci_with ethinyl estradiol MEDRT D008107 Liver Diseases DISEASE ci_with levonorgestrel MEDRT D008113 Liver Neoplasms DISEASE ci_with levonorgestrel MEDRT D008594 Menopause, Premature DISEASE may_treat ethinyl estradiol MEDRT D008595 Menorrhagia DISEASE may_treat ethinyl estradiol MEDRT D009376 Neoplasms, Hormone-Dependent DISEASE ci_with ethinyl estradiol MEDRT D015663 Osteoporosis, Postmenopausal DISEASE may_prevent ethinyl estradiol MEDRT D011247 Pregnancy DISEASE may_prevent ethinyl estradiol MEDRT D011247 Pregnancy DISEASE may_prevent levonorgestrel MEDRT D011247 Pregnancy DISEASE ci_with levonorgestrel MEDRT D011247 Pregnancy DISEASE ci_with ethinyl estradiol MEDRT D016649 Primary Ovarian Insufficiency DISEASE may_treat ethinyl estradiol MEDRT D011471 Prostatic Neoplasms DISEASE may_treat ethinyl estradiol MEDRT D013923 Thromboembolism DISEASE ci_with levonorgestrel MEDRT D013923 Thromboembolism DISEASE ci_with ethinyl estradiol MEDRT D013924 Thrombophlebitis DISEASE ci_with ethinyl estradiol MEDRT D013924 Thrombophlebitis DISEASE ci_with levonorgestrel MEDRT D064424 Tobacco Use DISEASE ci_with ethinyl estradiol MEDRT D014029 Tobacco Use Disorder DISEASE ci_with levonorgestrel MEDRT D014592 Uterine Hemorrhage DISEASE ci_with levonorgestrel MEDRT N0000000100 Estrogen Receptor Agonists MOA has_moa ethinyl estradiol MEDRT N0000000185 Progestational Hormone Receptor Agonists MOA has_moa levonorgestrel MEDRT N0000008311 Bone Formation Stimulation PE has_pe ethinyl estradiol MEDRT N0000008595 Decreased Embryonic Implantation PE has_pe ethinyl estradiol MEDRT N0000008595 Decreased Embryonic Implantation PE has_pe levonorgestrel MEDRT N0000009072 Hypothalamic Endocrine Activity Alteration PE has_pe levonorgestrel MEDRT N0000178478 Increased Blood Pressure PE ci_pe levonorgestrel MEDRT N0000009717 Inhibit Ovulation PE has_pe ethinyl estradiol MEDRT N0000009717 Inhibit Ovulation PE has_pe levonorgestrel MEDRT N0000009902 Vaginal Function Alteration PE has_pe ethinyl estradiol MEDRT N0000008289 Aromatic hydroxylation PK has_pk ethinyl estradiol MEDRT N0000000045 Fecal Excretion PK has_pk ethinyl estradiol MEDRT N0000000026 Hepatic Metabolism PK has_pk ethinyl estradiol MEDRT N0000000042 Renal Excretion PK has_pk ethinyl estradiol
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 0.02 MG / 0.15 MG ATTRIBUTES GENERAL_CARDINALITY MULTI ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US CODES ANDA ANDA206053 NAMES Prescribable Synonym ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet SOURCES Source Metathesaurus FDA Structured Product Labels